MYGNMyriad Genetics, Inc.

$454M

FY 2011 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$496M+23.4% YoY

Gross Profit

$431M87.0% margin

Operating Income

$180M36.4% margin

Net Income

$112M22.6% margin

EPS (Diluted)

$1.30

Cash Flow

Operating Cash Flow

$142M

Free Cash Flow

$132M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$691M

Total Liabilities

$55M

Stockholders' Equity

$636M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$496M	$402M	+23.4%
Gross Profit	$431M	$355M	+21.4%
Operating Income	$180M	$158M	+14.3%
Net Income	$112M	$101M	+11.4%

MYGN FY 2011 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena